<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-09T09:21:46+00:00">
  <iati-activity last-updated-datetime="2026-11-07T09:53:07+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-QNA-T-CDF-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Strengthening TB control in Kosovo - Kosovo (01-Apr-2016-31-Dec-2018)</narrative>
    </title>
    <description type="1">
      <narrative>Kosovo, Tuberculosis, Community Development Fund</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To reduce the overall incidence of TB notified cases from 46 per 100000 population in 2016  to 36 per 100000 in 2020. Objectives: To ensure equitable access to high quality diagnosis, treatment, care and prevention that is integrated and patient-centered, with a focus on vulnerable populations including children, ethnic minorities and on the prison population; To strengthen health support systems and use community systems to enable needs-based, sustainable and integrated interventions for key populations mostly affected by the TB epidemic.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Community Development Fund</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Community Development Fund</narrative>
    </participating-org>
    <other-identifier ref="QNA-T-CDFP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2016-04-01" />
    <activity-date type="2" iso-date="2016-04-01" />
    <activity-date type="3" iso-date="2018-12-31" />
    <activity-date type="4" iso-date="2018-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="XK" percentage="100">
      <narrative>Kosovo</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="100">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="b32ac381-3955-4b67-9a91-acd7417a31fe">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-05-02" />
      <value currency="USD" value-date="2016-05-02">1370437.81</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b8d53d21-8d29-4add-94ee-ce601c69551a">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-05-03" />
      <value currency="USD" value-date="2016-05-03">805565.68</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="53a9d744-9577-4e01-a8b8-a0de1ee28607">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-10-18" />
      <value currency="USD" value-date="2016-10-18">205156.97</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="02102e09-4e08-4858-84c7-384aa54e87a7">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-03-07" />
      <value currency="USD" value-date="2017-03-07">359715.16</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="68ab4dd3-9507-4b23-b4ed-e3134c1c0d3a">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-07-27" />
      <value currency="USD" value-date="2017-07-27">829686.46</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="95e768d8-0853-4eb0-9896-092af5b77206">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-28" />
      <value currency="USD" value-date="2017-07-28">360412.55</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b7197d05-970e-4065-8a28-2138fc22077b">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-11-09" />
      <value currency="USD" value-date="2017-11-09">14858.32</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9a199e4b-9dad-474e-ac19-a3542bc66bf9">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">28869.78</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="73fdb696-3a90-4280-9813-15dc60c51bfa">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-01-04" />
      <value currency="USD" value-date="2018-01-04">454415.59</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="987474aa-4e96-4fbd-b88c-c4fc3f8dc4f9">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-04-20" />
      <value currency="USD" value-date="2018-04-20">-28869.78</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ef5c5262-615c-4974-8188-9162bcedf216">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-04-20" />
      <value currency="USD" value-date="2018-04-20">56708.67</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a44c384a-56b9-4fb9-a1be-a04d27e1cd4b">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-06-18" />
      <value currency="USD" value-date="2018-06-18">9557.99</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="18142843-a1a8-45c7-a277-377d225192f6">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-06-29" />
      <value currency="USD" value-date="2018-06-29">9557.99</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b6cad7a4-6563-441e-8b69-be1ff60d8b39">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-09-21" />
      <value currency="USD" value-date="2018-09-21">9459.08</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="971d00cf-499e-467a-8c0d-de58b576aa74">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-09-25" />
      <value currency="USD" value-date="2018-09-25">9459.08</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="dc6390af-ab66-4f47-8143-3cf23b979023">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-12-31">30108.90</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a993509d-e52c-4ea6-854a-312587f0b641">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-02-13" />
      <value currency="USD" value-date="2019-02-13">21367.51</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4f236f4a-4093-4823-a1f2-4abcd9d07947">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-02-14" />
      <value currency="USD" value-date="2019-02-14">21367.51</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ba6074e0-2e9e-461b-a818-01ef36583c5c">
      <transaction-type code="7" />
      <transaction-date iso-date="2019-12-11" />
      <value currency="USD" value-date="2019-12-11">242145.98</value>
      <description>
        <narrative>Funds returned to the Global Fund from QNA-T-CDFP01.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Community Development Fund</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7296c571-0020-4ec1-bf1f-f2b824a671b1">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-12-13" />
      <value currency="USD" value-date="2019-12-13">-242145.98</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="42866819-2827-4c7d-95e2-b30af89400ec">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-06-13" />
      <value currency="USD" value-date="2020-06-13">5775.58</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a08951f7-3863-4876-b1fc-2f8ccad96ee4">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-06-13" />
      <value currency="USD" value-date="2020-06-13">-26599.78</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4bd88b5c-e1ba-4e37-aa05-30dcf6ae4486">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-06-15" />
      <value currency="USD" value-date="2020-06-15">-5775.58</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/QNA-T-CDF" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 0; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-04-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3; Denominator: 6; Percentage: 50%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 4.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 4.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 0; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 0; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 0; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-04-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3; Denominator: 3; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 4.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 4.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 834.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 273; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 393; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 441; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 403; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 431; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 0; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-04-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 836.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 717.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 790.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 721.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 284.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 336.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 385.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 301.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 420.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 745.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 700.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-07T09:53:07+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-QNA-T-CDF-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Strengthening TB control in Kosovo - Kosovo (01-Jan-2019-31-Dec-2021)</narrative>
    </title>
    <description type="1">
      <narrative>Kosovo, Tuberculosis, Community Development Fund</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To reduce the overall incidence of notified cases from 40.6 per 100,000 in 2017 to 34 per 100,000 in 2021 and maintain tuberculosis mortality in Kosovo below 2/100,000. Objectives: Successfully treat all cases of tuberculosis and maintain at least 85% the treatment success rate; Strengthen the early prevention and detection of tuberculosis by intensifying the active and passive findings of the cases by providing quality services and adequate measures of infection control and LTBI treatment of cases and other ongoing support; Establish and support national-level policies and legal framework and ensure greater government political and financial commitment to effective TB response in Kosovo; Improving patient-centred tuberculosis care through increased CSO engagement and strengthening public-private partnership; Improve national capacity to investigate and assess the impact of tuberculosis control and pre-elimination of interventions.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Community Development Fund</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Community Development Fund</narrative>
    </participating-org>
    <other-identifier ref="QNA-T-CDFP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2019-01-01" />
    <activity-date type="2" iso-date="2019-01-01" />
    <activity-date type="3" iso-date="2021-12-31" />
    <activity-date type="4" iso-date="2021-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="XK" percentage="100">
      <narrative>Kosovo</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12110" percentage="72.38">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="27.62">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="955f4722-71fb-4b46-8bd2-2d741fdad76b" percentage="0.4">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="34.5">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="4cd90b50-0924-481f-b5a1-22b7305b5dbb" percentage="0.04">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
        </description>
      </budget-item>
      <budget-item code="b0b850b8-142b-4100-bd18-2da244fde07f" percentage="0.31">
        <description>
          <narrative>RSSH -&gt; RSSH: Financial management systems -&gt; Public financial management (country or donor harmonized) systems</narrative>
        </description>
      </budget-item>
      <budget-item code="c9a33ca8-7a81-4232-9a19-1315956af36c" percentage="0.08">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="043741b4-bd0a-492c-8759-b4cac0a50e64" percentage="3.49">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Other health information systems and M&amp;E intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="5221e091-6641-4eee-b68d-9b5879a96a78" percentage="4.31">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="41f514b1-2e70-4f77-98c1-68e6052dc6a9" percentage="4.86">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="ad843466-bf87-44ef-9b83-217a8cfb22d0" percentage="1.7">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; National costed supply chain master plan, and implementation</narrative>
        </description>
      </budget-item>
      <budget-item code="7319638f-aa8e-41bc-b90c-e0eb35b6797c" percentage="3">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Other procurement supply chain management intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="b961b7bb-a99e-4922-86a2-61312d5fda69" percentage="0.28">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Procurement strategy</narrative>
        </description>
      </budget-item>
      <budget-item code="f9be36a8-948e-4f4f-860d-8e162eeaa510" percentage="12.16">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector governance and planning -&gt; National health sector strategies and financing</narrative>
        </description>
      </budget-item>
      <budget-item code="dfde36dd-26b2-4148-af2b-f52009f3470d" percentage="0.15">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector governance and planning -&gt; Other policy and governance intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="054acddf-7eaa-4d8d-b6a4-97e7f6a59a1e" percentage="3.23">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Capacity building for health workers, including those at community level</narrative>
        </description>
      </budget-item>
      <budget-item code="a9a15642-9d30-4ac6-85fe-0d687727c2d2" percentage="0.86">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Retention and scale-up of health workers, including for community health workers</narrative>
        </description>
      </budget-item>
      <budget-item code="defb4ca5-d606-456a-a463-d4939ec51355" percentage="2.42">
        <description>
          <narrative>RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Other service delivery intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="adeac860-3310-4061-ad9b-f184f1a3105e" percentage="0.57">
        <description>
          <narrative>RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Supportive policy and programmatic environment</narrative>
        </description>
      </budget-item>
      <budget-item code="1c7b99cb-f18c-499f-a55d-f7a0d6b99b21" percentage="0.47">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a4cf383e-48f0-4449-bdfd-4fefcc86f8e3" percentage="0.19">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Community MDR-TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="5def6266-3379-441d-b565-1d99bde3edd1" percentage="0.19">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Prevention (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="3637a37c-6acc-4a5b-b7e4-00640fd7e2ec" percentage="0.07">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="f7014493-22e9-4c03-96d0-144fbb3a254f" percentage="12.05">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="a0ec8795-341f-4d7b-9bdd-618cfc782127" percentage="0.15">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="cbff055b-fbc0-468b-9604-e69b10cbd9dd" percentage="1.95">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="1a563d22-2c21-4f9a-b142-805695850ac9" percentage="3.85">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="56afe3f2-1fa3-4fd3-b845-9ea07f4bfd51" percentage="0.42">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="fbc19cfa-87a0-4ea9-b0f8-b510eb8eab13" percentage="0.33">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Other TB care and prevention intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="accfbf9b-023f-4bd8-b952-bf1cb13e8e9b" percentage="3.72">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="0da342b5-b462-4465-bf9a-1fdb9d39596f" percentage="1.6">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Removing human rights and gender related barriers to TB care and prevention</narrative>
        </description>
      </budget-item>
      <budget-item code="edbef7da-ca99-4741-8ce0-ea3ba6cd3d3b" percentage="2.32">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="07fd3a5f-c9c2-4bda-a47f-8b744b7fd95e" percentage="0.13">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Other TB/HIV intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="92e11022-488c-4948-abb3-b61f3d9ca4f6" percentage="0.2">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">440377.43</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">584316.52</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">804552.26</value>
    </budget>
    <capital-spend percentage="11.96" />
    <transaction ref="482733da-04a2-443b-9c06-a22ee03bbc69">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-02-20" />
      <value currency="USD" value-date="2019-02-20">994532.10</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="281769c9-16bd-4dff-ae02-a3017962ec0f">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-02-21" />
      <value currency="USD" value-date="2019-02-21">256181.28</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="51ca849b-becd-47b4-8a0b-fa56b4e37cba">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-04-04" />
      <value currency="USD" value-date="2019-04-04">133883.48</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5dac041a-f591-485d-bfd9-2eb00dd88d8a">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-05-07" />
      <value currency="USD" value-date="2019-05-07">25071.54</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="226e54a0-cded-4fba-80d7-308cdfd221e2">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-07-09" />
      <value currency="USD" value-date="2019-07-09">107849.60</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f14d1254-d2e4-4f42-aa8f-95d9323f64b4">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-10-03" />
      <value currency="USD" value-date="2019-10-03">113999.63</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9f63c249-386b-427c-ab58-1022112fefa2">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-01-21" />
      <value currency="USD" value-date="2020-01-21">228340.85</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9e01fe98-8548-405a-bd4d-c80095b365e8">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-04-24" />
      <value currency="USD" value-date="2020-04-24">154277.25</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8c3d1797-2321-40ea-bdc6-59e862701d8f">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-06-10" />
      <value currency="USD" value-date="2020-06-10">547025.98</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ee47e1cb-25a1-4580-8a33-9a901823e135">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-06-16" />
      <value currency="USD" value-date="2020-06-16">208628.04</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a036c050-da72-476a-9401-851c061bb9d0">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-10-02" />
      <value currency="USD" value-date="2020-10-02">453445.63</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b5e99b02-6477-4ec9-84a0-4057b9c18b29">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-10-02" />
      <value currency="USD" value-date="2020-10-02">-338397.94</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="96aa1116-15b5-42d5-9b0c-5f5a6ed2b6de">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-10-07" />
      <value currency="USD" value-date="2020-10-07">115047.69</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="16942c2e-c470-4e10-bcfe-5b6d565d8673">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-10-21" />
      <value currency="USD" value-date="2020-10-21">4238.86</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d3753fa4-4763-4447-820b-fec633285b9a">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-01-28" />
      <value currency="USD" value-date="2021-01-28">330063.35</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e4586b06-a744-41d7-bf26-ea7b81a068e0">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-02-20" />
      <value currency="USD" value-date="2021-02-20">4122.86</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0ef122aa-f857-4008-b8b3-c6187404d88a">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-02-20" />
      <value currency="USD" value-date="2021-02-20">-4095.72</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4ad46379-68eb-4069-b8a1-b0e774b10803">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-02-26" />
      <value currency="USD" value-date="2021-02-26">4122.86</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="048b8b22-92b9-4c9c-917c-e7288cdb2c18">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-05-28" />
      <value currency="USD" value-date="2021-05-28">147541.62</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ec8acecd-3a3d-4303-9c68-cd77a58b828d">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-06-04" />
      <value currency="USD" value-date="2021-06-04">51727.57</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="770b6fa8-f0ec-4f5d-aa0a-9fdcf5846951">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-01" />
      <value currency="USD" value-date="2021-10-01">80904.70</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="74e94024-7c90-46af-a48d-b991e70efef4">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-01" />
      <value currency="USD" value-date="2021-10-01">3824.39</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a0483ae2-b189-437d-a23d-03194c26659a">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-01" />
      <value currency="USD" value-date="2021-10-01">3824.39</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b46ea9a2-0076-4b47-8610-c6174e964a5c">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-01" />
      <value currency="USD" value-date="2022-07-01">4014.35</value>
      <description>
        <narrative>Global Fund disbursement to QNA-T-CDFP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="98b78028-d83e-4e1d-9dc4-e8a06b7792d9">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-07-14" />
      <value currency="USD" value-date="2022-07-14">-1760.46</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="defa86c3-d79f-42c2-9dd9-813b460854c0">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-07-14" />
      <value currency="USD" value-date="2022-07-14">-25071.54</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="468ecb1e-7fb8-4954-9133-7e0f1e886374">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-07-14" />
      <value currency="USD" value-date="2022-07-14">26832.01</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7a0bdf4f-7b61-4d61-84f1-6244d509217a">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-07-25" />
      <value currency="USD" value-date="2022-07-25">-26832.01</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="78ab9ec1-3d8a-4ba9-8cf9-9a577ed11c0b">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-11-08" />
      <value currency="USD" value-date="2022-11-08">-3246.22</value>
      <description>
        <narrative>Global Fund commitment to QNA-T-CDFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="QNA-T-CDFP02-EXP-20191231">
      <transaction-type code="4" />
      <transaction-date iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-12-31">475411.70</value>
      <description>
        <narrative>Expenditure reported by Community Development Fund for QNA-T-CDFP02, Jan 2019 to Dec 2019.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Community Development Fund</narrative>
      </provider-org>
    </transaction>
    <transaction ref="QNA-T-CDFP02-EXP-20201231">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-12-31">472638.41</value>
      <description>
        <narrative>Expenditure reported by Community Development Fund for QNA-T-CDFP02, Jan 2020 to Dec 2020.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Community Development Fund</narrative>
      </provider-org>
    </transaction>
    <transaction ref="QNA-T-CDFP02-EXP-20211231">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-12-31">817483.80</value>
      <description>
        <narrative>Expenditure reported by Community Development Fund for QNA-T-CDFP02, Jan 2021 to Dec 2021.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Community Development Fund</narrative>
      </provider-org>
    </transaction>
    <transaction ref="QNA-T-CDFP02-EXP-20220630">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-06-30" />
      <value currency="USD" value-date="2022-06-30">9468.49</value>
      <description>
        <narrative>Expenditure reported by Community Development Fund for QNA-T-CDFP02, Jan 2022 to Jun 2022.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Community Development Fund</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/QNA-T-CDF" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 4.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 4.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 4.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 4.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 4.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 1; Denominator: 1; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="98.15">
          <comment>
            <narrative>Numerator: 265; Denominator: 270.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="90" />
          <actual value="88.7">
            <comment>
              <narrative>Numerator: 220; Denominator: 248.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="90" />
          <actual value="75.2">
            <comment>
              <narrative>Numerator: 115; Denominator: 153.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90" />
          <actual value="57.9">
            <comment>
              <narrative>Numerator: 110; Denominator: 190.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 20.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          <comment>
            <narrative>Numerator: 20.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 20.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 25.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 25.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 20.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 30.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 15.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
            <comment>
              <narrative>Numerator: 0; Denominator: 445; Percentage: 0%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="712" />
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="685" />
          <actual value="603" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="650" />
          <actual value="438" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="615" />
          <actual value="445" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="42.28">
          <comment>
            <narrative>Numerator: 301; Denominator: 712.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 548; Denominator: 685.</narrative>
            </comment>
          </target>
          <actual value="70.3">
            <comment>
              <narrative>Numerator: 424; Denominator: 603.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 585; Denominator: 650.</narrative>
            </comment>
          </target>
          <actual value="40.2">
            <comment>
              <narrative>Numerator: 176; Denominator: 438.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90.08">
            <comment>
              <narrative>Numerator: 554; Denominator: 615.</narrative>
            </comment>
          </target>
          <actual value="43.8">
            <comment>
              <narrative>Numerator: 195; Denominator: 445.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>